Your browser doesn't support javascript.
loading
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma.
Crochet, Gilles; Iacoboni, Gloria; Couturier, Audrey; Bachy, Emmanuel; Iraola-Truchuelo, Josu; Gastinne, Thomas; Cartron, Guillaume; Fradon, Tom; Lesne, Bastien; Kwon, Mi; Gounot, Romain; Martínez-Cibrian, Nuria; Castilla-Llorente, Cristina; Abrisqueta, Pau; Guerreiro, Manuel; Sarkozy, Clémentine; Aspa-Cilleruelo, Jose María; Camus, Vincent; Guidez, Stéphanie; Chauchet, Adrien; Deconinck, Eric; Bouabdallah, Krimo; Bosch, Francesc; Barba, Pere; Morschhauser, Franck; Houot, Roch.
Affiliation
  • Crochet G; Centre Hospitalier Universitaire UCLouvain Namur, Yvoir, Belgium.
  • Iacoboni G; Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Couturier A; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Bachy E; Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Iraola-Truchuelo J; Hospices Civils de Lyon, Pierre-Bénite, France.
  • Gastinne T; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Cartron G; Nantes University Hospital, Nantes, France.
  • Fradon T; Centre Hospitalier Universitaire Montpellier, Montpellier, France.
  • Lesne B; LYSARC, The Lymphoma Academic Research Organization, Pierre-Bénite, France.
  • Kwon M; LYSARC, The Lymphoma Academic Research Organization, Pierre-Bénite, France.
  • Gounot R; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Martínez-Cibrian N; Hôpital Henri Mondor, Créteil, France.
  • Castilla-Llorente C; Hospital Clínic, Barcelona, Spain.
  • Abrisqueta P; Institut de Cancérologie Gustave Roussy, Villejuif, France.
  • Guerreiro M; Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Sarkozy C; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Aspa-Cilleruelo JM; Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Camus V; Institut Gustave Roussy, Villejuif, France.
  • Guidez S; Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, Madrid, Spain.
  • Chauchet A; Centre Henri Becquerel, Rouen, France.
  • Deconinck E; Centre Hospitalier Universitaire Poitiers, Poitiers, France.
  • Bouabdallah K; Centre Hospitalier Universitaire Besançon, Besançon, France.
  • Bosch F; Centre Hospitalier Universitaire Besançon, Besançon, France.
  • Barba P; Centre Hospitalier Universitaire Haut-Leveque, Pessac, France.
  • Morschhauser F; Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Houot R; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Blood ; 144(3): 334-338, 2024 Jul 18.
Article in En | MEDLINE | ID: mdl-38657242
ABSTRACT
ABSTRACT In this retrospective study, chimeric antigen receptor T cells remained effective in patients with relapsed/refractory large B-cell lymphoma after prior exposure to bispecific antibodies (BsAbs) targeting different antigens. These results are relevant to clinical practice, particularly given the increasing use of BsAbs in earlier treatment lines.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Antibodies, Bispecific Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2024 Type: Article Affiliation country: Belgium
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Antibodies, Bispecific Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2024 Type: Article Affiliation country: Belgium